PSY
Defiance Next Gen Altered Experience ETF$5.90— (—)AUM $4.7MER 0.75%NAV $5.93Holdings 2Inception May 2021
Price Chart
Key Statistics
Previous Close
—Day Range
N/A52-Week Range
N/AAvg Volume
0Dividend Yield
—Expense Ratio
0.75%AUM
$4.7MShares Outstanding
—ETF Grades
?ETF Grades compare this fund against others in the same category using percentile rankings across six factors. Grades range from A+ (top 5%) to F (bottom 20%). Updated daily.Sector Breakdown
| Sector | Weight % |
|---|---|
| Healthcare | 82.68% |
| Consumer Cyclical | 6.43% |
| Consumer Defensive | 5.65% |
| Real Estate | 5.25% |
Country Allocation
| Country | Weight % |
|---|---|
| Other | 100.00% |
Fund Information
- Category
- Healthcare
- Inception Date
- May 27, 2021
- Description
- The index is a rules-based index that tracks the performance of a portfolio of companies conducting legal activities under the national laws of the applicable country related to medical psychedelics, medical cannabis, cannabis pharmaceuticals and cannabidiol derivatives, and ketamine. The fund uses a “replication” strategy to achieve its investment objective, it will invest in all of the component securities of the index in the same approximate proportions as in the index. It is non-diversified.
Similar ETFs
The Defiance Next Gen Altered Experience ETF (PSY) is an exchange-traded fund that launched on May 27, 2021. It currently manages $4.7M in assets under management. The fund charges an expense ratio of 0.75%. The fund holds 2 securities in its portfolio. It falls under the Healthcare category.
Top 10 holdings represent 100.0% of the fund
| Rank | Symbol | Name | Weight % | Shares | Market Value |
|---|---|---|---|---|---|
| 1 | Cash&Other | Cash & Other | 100.00% | 5,043,031 | $5.0M |
| 2 | 1914272D.TO | ALT HOUSE CANNABIS INC | 0.00% | 10,690 | $0 |
Detailed Returns
| Period | Return | ETF |
|---|---|---|
| 1D | — | |
| 1W | — | |
| 1M | — | |
| 3M | — | |
| 6M | — | |
| YTD | — | |
| 1Y | — | |
| 3Y | — | |
| 5Y | -77.76% |
Moving Averages
20-Day MA
—
50-Day MA
—
200-Day MA
—
Price with Moving Averages
Support & Resistance
52-Week High
—
Current Price
$5.90
52-Week Low
—
Current Yield
—
Annual Dividend
—
Frequency
—
Last Ex-Date
—
Dividends
No dividend data available for this ETF.
Category Comparison
| Metric | PSY | Healthcare(212 ETFs) | Cannabis(25 ETFs) |
|---|---|---|---|
| Fund Info | |||
| Expense Ratio | 0.75% | 0.61% | 0.68% |
| AUM | $4.7M | $1.20B | $757.8M |
| Dividend Yield | — | 3.25% | 5.42% |
| Avg Volume | 0 | 344.9K | 872.2K |
| Holdings | 2 | 181 | 329 |
| Performance | |||
| 1-Month Return | — | +5.25% | +15.17% |
| 6-Month Return | — | +6.85% | +0.94% |
| YTD Return | — | +2.72% | +0.10% |
| 1-Year Return | — | +30.99% | +54.66% |
Compare with Another ETF
Search for an ETF to compare with PSY:
FREE DOWNLOAD
The Beginner's Guide to ETFs
20 pages. Zero fluff. Everything you need to start investing in ETFs.
No spam. Unsubscribe anytime.